BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30413200)

  • 1. The effect of model selection on cost-effectiveness research: a comparison of kidney function-based microsimulation and disease grade-based microsimulation in chronic kidney disease modeling.
    Hiragi S; Tamura H; Goto R; Kuroda T
    BMC Med Inform Decis Mak; 2018 Nov; 18(1):94. PubMed ID: 30413200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
    Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
    Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of Pneumococcal Vaccination Among Patients With CKD in the United States.
    Ishigami J; Padula WV; Grams ME; Chang AR; Jaar B; Gansevoort RT; Bridges JFP; Kovesdy CP; Uchida S; Coresh J; Matsushita K
    Am J Kidney Dis; 2019 Jul; 74(1):23-35. PubMed ID: 30898360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD.
    Tangri N; Chadban S; Cabrera C; Retat L; Sánchez JJG
    Adv Ther; 2023 Jan; 40(1):265-281. PubMed ID: 36307575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease.
    Kazemian P; Costantini S; Neilan AM; Resch SC; Walensky RP; Weinstein MC; Freedberg KA
    J Biomed Inform; 2020 Jul; 107():103475. PubMed ID: 32526280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
    Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
    J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.
    Lin E; Chertow GM; Yan B; Malcolm E; Goldhaber-Fiebert JD
    PLoS Med; 2018 Mar; 15(3):e1002532. PubMed ID: 29584720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost Effectiveness of Difelikefalin Compared to Standard Care for Treating Chronic Kidney Disease Associated Pruritus (CKD-aP) in People with Kidney Failure Receiving Haemodialysis.
    Thokala P; Hnynn Si PE; Hernandez Alava M; Sasso A; Schaufler T; Soro M; Fotheringham J
    Pharmacoeconomics; 2023 Apr; 41(4):457-466. PubMed ID: 36735201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The costs and benefits of automatic estimated glomerular filtration rate reporting.
    den Hartog JR; Reese PP; Cizman B; Feldman HI
    Clin J Am Soc Nephrol; 2009 Feb; 4(2):419-27. PubMed ID: 19176794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea.
    Go DS; Kim SH; Park J; Ryu DR; Lee HJ; Jo MW
    Nephrology (Carlton); 2019 Jan; 24(1):56-64. PubMed ID: 29206319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study.
    Al-Shamsi S; Oulhaj A; Regmi D; Govender RD
    BMC Nephrol; 2019 Aug; 20(1):325. PubMed ID: 31429712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD.
    Madero M; Katz R; Murphy R; Newman A; Patel K; Ix J; Peralta C; Satterfield S; Fried L; Shlipak M; Sarnak M
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):893-903. PubMed ID: 28522656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accounting for Age in the Definition of Chronic Kidney Disease.
    Liu P; Quinn RR; Lam NN; Elliott MJ; Xu Y; James MT; Manns B; Ravani P
    JAMA Intern Med; 2021 Oct; 181(10):1359-1366. PubMed ID: 34459844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prediction models for progression of chronic kidney disease to end-stage kidney failure under pre-dialysis nephrology care: results from the Chronic Kidney Disease Japan Cohort Study.
    Hasegawa T; Sakamaki K; Koiwa F; Akizawa T; Hishida A;
    Clin Exp Nephrol; 2019 Feb; 23(2):189-198. PubMed ID: 30069609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.
    Klarin D; Lancaster RT; Ergul E; Bertges D; Goodney P; Schermerhorn ML; Cambria RP; Patel VI;
    J Vasc Surg; 2016 Nov; 64(5):1295-1302. PubMed ID: 27776697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cohort profile: the chronic kidney disease prognosis consortium.
    Matsushita K; Ballew SH; Astor BC; Jong PE; Gansevoort RT; Hemmelgarn BR; Levey AS; Levin A; Wen CP; Woodward M; Coresh J;
    Int J Epidemiol; 2013 Dec; 42(6):1660-8. PubMed ID: 23243116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of enhanced syphilis screening among HIV-positive men who have sex with men: a microsimulation model.
    Tuite AR; Burchell AN; Fisman DN
    PLoS One; 2014; 9(7):e101240. PubMed ID: 24983455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease.
    Dai Z; Zhu J; Huang H; Fang L; Lin Y; Huang S; Xie F; Sheng N; Liang X
    Nephrology (Carlton); 2020 May; 25(5):398-405. PubMed ID: 31412142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation.
    Corbett M; Duarte A; Llewellyn A; Altunkaya J; Harden M; Harris M; Walker S; Palmer S; Dias S; Soares M
    Health Technol Assess; 2020 Aug; 24(39):1-248. PubMed ID: 32840478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.